Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-07-29

Clinical Trial Update: Abatacept for the Treatment of Relapsing, Non-Severe, Granulomatosis With Polyangiitis (Wegener's) [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating abatacept for relapsing, non-severe granulomatosis with polyangiitis (Wegener's). No trial re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Abatacept (abatacept)

Snippet

Sponsor: University of South Florida | Conditions: Granulomatosis With Polyangiitis (Wegener's), Granulomatosis With Polyangiitis | Phase 3 | Status: COMPLETED